A 36-week, single-arm, open-label study to evaluate the safety and tolerability of ferric citrate in children with hyperphosphatemia related to chronic kidney disease.

Is this Study for You?

Let's Get Started!

Description

A single arm trial evaluating efficacy of ferric citrate over 36 weeks in pediatric patients with hyperphosphatemia related to CKD.

Details
Age

Child

Eligibility

12-17 years old, diagnosis of CKD

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Weiwen Shih

Weiwen Shih

Study ID

Protocol Number: 23-0073

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers